Alzheimer's disease and anaesthesia: Potential relationships and clinical implications

被引:2
|
作者
Andre, D. [1 ]
Dartigues, J. -F. [2 ]
Sztark, F. [1 ]
机构
[1] Univ Bordeaux 2, CHU Bordeaux, Grp Hosp Pellegrin, Serv Anesthesie Reanimat 1, F-33076 Bordeaux, France
[2] Univ Bordeaux 2, INSERM, U897, F-33076 Bordeaux, France
来源
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION | 2011年 / 30卷 / 01期
关键词
Alzheimer's disease; Postoperative cognitive dysfunction; Anaesthetics neurotoxicity; POSTOPERATIVE COGNITIVE DYSFUNCTION; NITROUS OXIDE ANESTHESIA; ISOFLURANE INDUCES APOPTOSIS; INDUCED NEURONAL APOPTOSIS; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN-E GENOTYPE; BETA-PEPTIDE; GLUCOSE DEPRIVATION; INTRACELLULAR CA2+; GENERAL-ANESTHESIA;
D O I
10.1016/j.annfar.2010.10.013
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Alzheimer's disease is the most common form of dementia. As the aging population increases, Alzheimer's disease is becoming a major concern of Public Health. Many molecular lesions have been detected in Alzheimer's disease, but physiopathology is still poorly understood. If the neurotoxicity of anaesthetics in human remains debatable, perioperative period is certainly a high-risk factor for cognitive impairment, especially in elderly population. Large clinical studies are required to develop new strategies for perioperative management in such patients, including the adjustment of anaesthesia techniques. Before that, information of patient and its relatives and a particular attention for elderly during anaesthesia and perioperative period should be considered. (C) 2010 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 50 条
  • [41] Autoantibodies in Alzheimer's disease:potential biomarkers,pathogenic roles,and therapeutic implications
    Jianming Wu
    Ling Li
    The Journal of Biomedical Research, 2016, 30 (05) : 361 - 372
  • [42] Insulin resistance and Alzheimer's disease pathogenesis: Potential mechanisms and implications for treatment
    Craft, Suzanne
    CURRENT ALZHEIMER RESEARCH, 2007, 4 (02) : 147 - 152
  • [43] Investigation of Potential Brain Microbiome in Alzheimer's Disease: Implications of Study Bias
    Westfall, Susan
    Dinh, Duy M.
    Pasinetti, Giulio Maria
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (02) : 559 - 570
  • [44] Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications
    Wu, Jianming
    Li, Ling
    JOURNAL OF BIOMEDICAL RESEARCH, 2016, 30 (05): : 361 - 372
  • [45] The treatment of Alzheimer's disease using Chinese Medicinal Plants: From disease models to potential clinical applications
    Su, Yang
    Wang, Qiuhong
    Wang, Changfu
    Chan, Kelvin
    Sun, Yanping
    Kuang, Haixue
    JOURNAL OF ETHNOPHARMACOLOGY, 2014, 152 (03) : 403 - 423
  • [46] Implications of Glycosylation in Alzheimer's Disease
    Haukedal, Henriette
    Freude, Kristine K.
    FRONTIERS IN NEUROSCIENCE, 2021, 14
  • [47] The Implications of Autophagy in Alzheimer's Disease
    Hamano, Tadanori
    Hayashi, Kouji
    Shirafuji, Norimichi
    Nakamoto, Yasunari
    CURRENT ALZHEIMER RESEARCH, 2018, 15 (14) : 1283 - 1296
  • [48] Implications of Microorganisms in Alzheimer's Disease
    Yadav, Pardeep
    Lee, Yeon-Hee
    Panday, Hrithika
    Kant, Shubham
    Bajwa, Neha
    Parashar, Ritika
    Jha, Saurabh Kumar
    Jha, Niraj Kumar
    Nand, Parma
    Lee, Sang-Soo
    Jha, Abhimanyu Kumar
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (10) : 4584 - 4615
  • [49] Clusterin as a Potential Biomarker of Obesity-Related Alzheimer's Disease Risk
    Bradley, David
    BIOMARKER INSIGHTS, 2020, 15
  • [50] Potential of neural stem cell-based therapies for Alzheimer's disease
    Li, Xue-Yuan
    Bao, Xin-Jie
    Wang, Ren-Zhi
    JOURNAL OF NEUROSCIENCE RESEARCH, 2015, 93 (09) : 1313 - 1324